We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

772:HKEXChina Literature Ltd. Analysis

Data as of 2026-03-15 - not real-time

NT$50.10

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The stock is trading just above its 20‑day simple moving average, indicating it is barely holding its short‑term trend. However, the 50‑day average sits well below the current price, showing a gap between recent momentum and longer‑term direction. The 200‑day average remains significantly higher, confirming that the broader trend is still bearish. RSI hovers around the midpoint, suggesting neither strong buying nor selling pressure. The MACD line sits below its signal line, generating a bearish signal that aligns with the neutral overall trend. Volume has been on a downward trajectory, which weakens the support for any near‑term rally.
Valuation metrics are stretched, with a price‑to‑earnings multiple far above the industry average and a discounted cash‑flow estimate that suggests the stock is overvalued. The company’s dividend yield looks attractive, but the payout ratio exceeds earnings, raising doubts about its sustainability. Profitability is thin, and free cash flow is negative, highlighting cash‑generation concerns. High volatility and a beta close to market levels add to price uncertainty. The balance sheet shows a modest debt load relative to equity but limited cash cushions. Given these factors, the outlook leans toward caution across all horizons.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • bearish MACD signal
  • price near resistance level
  • decreasing trading volume

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • significant overvaluation relative to DCF
  • weak free cash flow generation
  • high dividend yield but unsustainable payout

Long Term

> 3 years
Cautious
Model confidence: 6/10

Key Factors

  • persistent cash‑flow deficits
  • valuation far above industry norms
  • elevated volatility and sector risk

Key Metrics & Analysis

Financial Health

Revenue Growth-14.00%
Profit Margin5.72%
P/E Ratio98.2
ROE2.51%
ROA1.33%
Debt/Equity17.87
P/B Ratio2.2
Op. Cash FlowNT$175.8M
Free Cash FlowNT$-500796736
Industry P/E33.7

Technical Analysis

TrendNeutral
RSI49.8
SupportNT$46.35
ResistanceNT$57.20
MA 20NT$50.18
MA 50NT$49.33
MA 200NT$60.27
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Fair ValueNT$31.21
GradeOvervalued
TypeValue
Dividend Yield3.99%

Risk Assessment

Beta0.99
Volatility40.01%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.